Date | Product | Disease | Phase | Company | Therapeutic area |
---|---|---|---|---|---|
2011-11-22 | PXT-3003 (fixed-dose combination of (R-S) baclofen, naltrexone hydrochloride and D-sorbitol) | Charcot-Marie-Tooth disease | 2 | Pharnext (France) | Rare diseases - Genetic diseases - Neurological diseases |
2011-11-19 | Enzyme Replacement Therapy (ERT) | Pompe disease and other metabolic disorders | UGent and Vrije Universiteit (Belgium) Oxyrane (Belgium-UK-USA) | Genetic diseases - Rare diseases - Metabolic diseases | |
2011-11-16 | albiglutide | type 2 diabetes | 3 | GSK (UK) | Metabolic diseases |
2011-11-15 | Fibrocaps™ | 2 | ProFibrix (The Netherlands) | Hemostasis | |
2011-11-13 | Xarelto® (rivaroxaban) | Secondary Prevention of Acute Coronary Syndrome (ACS) |
3 | Bayer HealthCare (Germany) | Cardiovascular diseases |
2011-11-12 | Certican® (everolimus) | liver transplantation |
3 | Novartis (Switzerland) | Transplantation |
2011-11-10 | REGN727/SAR236553 | elevated low-density lipoprotein cholesterol |
2 | Sanofi (France) Regeneron Pharmaceuticals (USA) | Cardiovascular diseases - Metabolic diseases |
2011-11-10 | ALX-0081 | Acute coronary syndrome (ACS) |
2 | Ablynx (Belgium) | Cardiovascular diseases |
2011-11-10 | RPL554 | chronic obstructive pulmonary disease (COPD) | 2a | Verona Pharma (UK) | Respiratory diseases |
2011-11-09 | ND0611 Dermal Patch | Parkinson's disease | 1-2 | NeuroDerm (Israel) | Neurodegenerative diseases - CNS diseases |
2011-11-08 | BI 201335 | chronic hepatitis C | 2b | Boehringer Ingelheim (Germany) | Infectious diseases |
2011-11-08 | CYT107 (Recombinant human interleukin-7) | hepatitis C
|
1-2a | Cytheris (France) | Infectious diseases |
2011-11-08 | CV301 | 2 | Bavarian Nordic (Denmark) | Cancer Oncology | |
2011-11-07 | BI 201335 | chronic hepatitis C | 2b | Boehringer Ingelheim (Germany) | Infectious diseases |
2011-11-07 | eltrombopag | hepatitis C virus related thrombocytopenia |
3 | GSK (UK) | Infectious diseases |
2011-11-07 | Vidofludimus | rheumatoid arthritis |
2b | 4SC (Germany) | Autoimmune diseases – Inflammatory diseases - Rheumatic diseases |
2011-11-07 | simeprevir (TMC435) | 2b | Tibotec Pharmaceuticals-J&J (Ireland - USA) Medivir (Sweden) | Infectious diseases | |
2011-11-07 | CV9201 | non small cell lung cancer (NSLC) |
1-2a | CureVac (Germany) | Cancer - Oncology |
2011-11-07 | DegludecPlus | type 2 diabetes
|
3a | Novo Nordisk (Denmark) | Metabolic diseases |
2011-11-07 | ACZ885 (canakimumab) | systemic juvenile idiopathic arthritis (SJIA) |
3 | Novartis (Switzerland) | Autoimmune diseases - Rare diseases |